Investors

Welcome to our Investor Centre

Please click on the Profiles below to see more details on our other clients:

All of the information contained within this website has been compiled from sources believed to be reliable, but no warranty, expressed or implied, is given that the information is complete or accurate or that it is fit for a particular purpose. All such warranties are expressly disclaimed and excluded. Any opinions, recommendations and forecasts referred to are not those of Walbrook PR Limited but are expressly those of third parties, such as investment analysts and financial journalists. Such opinions, recommendations and forecasts may have been superseded and thus may not necessarily be the current opinions, recommendations and forecasts of the relevant analyst/broker. None of the content of this website should be construed as an offer to buy or sell, or a solicitation of an offer to buy or sell, the securities of any listed Company mentioned or featured herein as it is for information only. Any recommendations referred to by third parties do not necessarily imply the suitability of particular securities for individual situations. The value of securities and the income from them may fluctuate. It should be remembered that past performance is not necessarily a guide to future performance. You are strongly advised to seek guidance from a professional investment adviser before entering into any contract to buy or sell any security featured herein. By reading this disclaimer, and ticking the box below, you confirm that you accept and understand its content, and that you shall not hold Walbrook PR Limited, its directors and staff nor any of its subsidiaries or connected companies liable for any loss that you may sustain should you decide to buy or sell any of the mentioned securities.

Optibiotix Health Plc

Company Profile

Company website
Sector
Pharmaceuticals & Biotechnology (Biotechnology)
Description

OptiBiotix Health plc (AIM: OPTI) develops compounds which modify the human microbiome - the collective genome of the microbes in the body - to prevent and manage human disease.

Investor Access

08 Aug
Event information

Management will hold the company’s AGM on 8 August 2024


Please check here for more information: https://www.londonstockexchange.com/news-article/OPTI/final-results/16541766

Venue
Offices of Peterhouse Capital Limited, 3rd Floor, 80 Cheapside, London EC2V 6EE.
Time
Thursday 8 August 2024 at 12pm
Financial Calendar
 Event Date
Year End31 December
Half  Year End30 June
Preliminary Results28 June
Interim Results*September
AGM8 August

* Months based on previous announcements of this kind